Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 108 (6) , 938-945
- https://doi.org/10.1067/mai.2001.120134
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of Cumulative Single Doses of Inhaled Salbutamol Enantiomers in Asthmatic SubjectsPulmonary Pharmacology & Therapeutics, 1999
- Asthma from the perspective of the patientJournal of Allergy and Clinical Immunology, 1999
- Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthmaJournal of Allergy and Clinical Immunology, 1998
- Ketotifen inhibits exacerbation of allergic airway hyperreactivity by racemic salbutamol in the guinea pigJournal of Allergy and Clinical Immunology, 1993
- Exacerbation of Airway Hyperreactivity by (±)Salbutamol in Sensitized Guinea PigsThe Japanese Journal of Pharmacology, 1993
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Relative Amount of Albuterol Delivered to Lung Receptors from a Metered-dose Inhaler and Nebulizer SolutionChest, 1992
- FDA'S policy statement for the development of new stereoisomeric drugsChirality, 1992
- Regular inhaled beta-agonist treatment in bronchial asthmaThe Lancet, 1990
- Absolute configuration of the optical isomers of salbutamolJournal of Medicinal Chemistry, 1971